Browsing "1. Journal Papers" by Author : 3539

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 49 to 108 of 160

This table browses all dspace content
Issue DateTitleJournal Title
2015Early CMV replication and subsequent chronic GVHD have a significant anti-leukemic effect after allogeneic HSCT in acute myeloid leukemiaANNALS OF HEMATOLOGY
2019Early Cytomegalovirus Reactivation and Expansion of CD56brightCD16dim/-DNAM1+ Natural Killer Cells Are Associated with Antileukemia Effect after Haploidentical Stem Cell Transplantation in Acute LeukemiaBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
2014Early response to high-dose methotrexate, vincristine, and procarbazine chemotherapy-adapted strategy for primary CNS lymphoma: no consolidation therapy for patients achieving early complete response.ANNALS OF HEMATOLOGY
2016Effect of major histocompatibility complex haplotype matching by C4 and MICA genotyping on acute graft versus host disease in unrelated hematopoietic stem cell transplantation.HUMAN IMMUNOLOGY
2004Elevated S-phase kinase-associated protein 2 protein expression in acute myelogenous leukemia: its association with constitutive phosphorylation of phosphatase and tensin homologue protein and poor prognosis CLINICAL CANCER RESEARCH
2016Enhanced autophagy in cytarabine arabinoside-resistant U937 leukemia cells and its potential as a target for overcoming resistance MOLECULAR MEDICINE REPORTS
2017Epidemiology and Risk Factors for Invasive Fungal Diseases among Allogeneic Hematopoietic Stem Cell Transplant Recipients in Korea: Results of "RISK" StudyBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
2005EPO 사용이 없었던 말기신부전으로 혈액투석 중인 환자에서 발생한 적혈구증가증 1예 Korean Journal of Nephrology (대한신장학회지)
2022Erythroid Differentiation of Induced Pluripotent Stem Cells Co-cultured with OP9 Cells for Diagnostic Purposes ANNALS OF LABORATORY MEDICINE
2020Exercise barriers and facilitators during hematopoietic stem cell transplantation: a qualitative study BMJ OPEN
2017Factors associated with pulmonary toxicity after myeloablative conditioning using fractionated total body irradiation RADIATION ONCOLOGY JOURNAL
2013Fludarabine, cytarabine, and attenuated-dose idarubicin (m-FLAI) combination therapy for elderly acute myeloid leukemia patientsAMERICAN JOURNAL OF HEMATOLOGY
2018HBsAg-Negative, Anti-HBc-Negative Patients Still Have a Risk of Hepatitis B Virus-Related Hepatitis after Autologous Stem Cell Transplantation for Multiple Myeloma or Malignant Lymphoma CANCER RESEARCH AND TREATMENT
2015Hemophagocytic Lymphohistiocytosis after Lung Transplantation Korean Journal of Critical Care Medicine
2006High dose chemotherapy and autologous stem cell transplantation in non-Hodgkin's lymphoma: An eight-year experience YONSEI MEDICAL JOURNAL
2016High pre-transplant serum ferritin and busulfan-thiotepa conditioning regimen as risk factors for hepatic sinusoidal obstructive syndrome after autologous stem cell transplantation in patients with malignant lymphoma.LEUKEMIA & LYMPHOMA
2014High-Dose Etoposide Plus Granulocyte Colony-Stimulating Factor as an Effective Chemomobilization Regimen for Autologous Stem Cell Transplantation in Patients with Non-Hodgkin Lymphoma Previously Treated with CHOP-based Chemotherapy: A Study from the Consortium for Improving Survival of LymphomaBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
2020Identification of MYC as an antinecroptotic protein that stifles RIPK1-RIPK3 complex formation PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
2022Ig Gene Clonality Analysis Using Next-Generation Sequencing for Improved Minimal Residual Disease Detection with Significant Prognostic Value in Multiple Myeloma Patients JOURNAL OF MOLECULAR DIAGNOSTICS
2020Immunosuppressive role of CD11b + CD33 + HLA-DR - myeloid-derived suppressor cells-like blast subpopulation in acute myeloid leukemia CANCER MEDICINE
2023In vitro erythrocyte production using human-induced pluripotent stem cells: determining the best hematopoietic stem cell sources STEM CELL RESEARCH & THERAPY
2014Incidence and risk factors for carbapenem- and multidrug-resistant Acinetobacter baumannii bacteremia in hematopoietic stem cell transplantation recipientsSCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
2019Induction of apoptosis and differentiation by Na/H exchanger 1 modulation in acute myeloid leukemia cellsBIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
2003Induction of Apoptosis by Apicidin, a Histone Deacetylase Inhibitor, via the Activation of Mitochondria-Dependent Caspase Cascades in Human Bcr-Abl-Positive Leukemia Cells CLINICAL CANCER RESEARCH
2015Induction of cytosine arabinoside-resistant human myeloid leukemia cell death through autophagy regulation by hydroxychloroquineBIOMEDICINE & PHARMACOTHERAPY
2013Influence of enzyme and transporter polymorphisms on trough imatinib concentration and clinical response in chronic myeloid leukemia patients ANNALS OF ONCOLOGY
2005Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remissionBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
2010Inhibition of CK2{alpha} and PI3K/Akt synergistically induces apoptosis of CD34+CD38- leukaemia cells while sparing haematopoietic stem cells.ANTICANCER RESEARCH
2004Isolated Extramedullary Relapse of Acute Myelogenous Leukemia as a Uterine Granulocytic Sarcoma in an Allogeneic Hematopoietic Stem Cell Transplantation Recipient YONSEI MEDICAL JOURNAL
2013Karyotypic change between diagnosis and relapse as a predictor of salvage therapy outcome in AML patients BLOOD RESEARCH
2002Long-term bone marrow culture-derived stromal fibroblasts as a potential target for gene therapy in acute myelogenous leukemia.LEUKEMIA RESEARCH
2007Long-term outcome after prophylactic lamivudine treatment on hepatitis B virus reactivation in non-Hodgkin's lymphoma. YONSEI MEDICAL JOURNAL
2011Lymphopenia is an important prognostic factor in peripheral T-cell lymphoma (NOS) treated with anthracycline-containing chemotherapy. JOURNAL OF HEMATOLOGY & ONCOLOGY
2014Monoclonal and polyclonal gammopathy measured by serum free light chain and immunofixation subdivide the clinical outcomes of diffuse large B-cell lymphoma according to molecular classificationANNALS OF HEMATOLOGY
2014Multicenter study evaluating the impact of hypomethylating agents as bridging therapy to hematopoietic stem cell transplantation in myelodysplastic syndromesINTERNATIONAL JOURNAL OF HEMATOLOGY
2010Myeloperoxidase expression as a potential determinant of parthenolide-induced apoptosis in leukemia bulk and leukemia stem cells JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
2012Myeloperoxidase expression in acute myeloid leukemia helps identifying patients to benefit from transplant YONSEI MEDICAL JOURNAL
2009Natural polyphenols antagonize the antimyeloma activity of proteasome inhibitor bortezomib by direct chemical interactionBRITISH JOURNAL OF HAEMATOLOGY
2006Nine-year survival of lymphoblastic lymphoma patients YONSEI MEDICAL JOURNAL
2001NK/T 세포 림프종 환자에서 시행된 비골수제거성 조혈모세포이식 대한조혈모세포이식학회지
2012Patient counseling program to improve the compliance to imatinib in chronic myeloid leukemia patientsMEDICAL ONCOLOGY
2013Patterns of care and treatment outcomes for primary thyroid lymphoma: a single institution study RADIATION ONCOLOGY JOURNAL
2020PERK/NRF2 and Autophagy Form a Resistance Mechanism Against G9a Inhibition in Leukemia Stem Cells JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
2022Pevonedistat in East Asian patients with acute myeloid leukemia or myelodysplastic syndromes: a phase 1/1b study to evaluate safety, pharmacokinetics and activity as a single agent and in combination with azacitidine JOURNAL OF HEMATOLOGY & ONCOLOGY
2003Phosphatase and tensin homologue phosphorylation in the C-terminal regulatory domain is frequently observed in acute myeloid leukaemia and associated with poor clinical outcomeBRITISH JOURNAL OF HAEMATOLOGY
2018Platelet storage induces accelerated desialylation of platelets and increases hepatic thrombopoietin production JOURNAL OF TRANSLATIONAL MEDICINE
2024Poor Mobilization-Associated Factors in Autologous Hematopoietic Stem Cell Harvest CANCERS
2015Prediction of survival by applying current prognostic models in diffuse large B-cell lymphoma treated with R-CHOP followed by autologous transplantation BLOOD RESEARCH
2022Predictive Factors of Event-Free Survival at 24 Months in Patients with Peripheral T-Cell Lymphoma: A Retrospective Study CANCER RESEARCH AND TREATMENT
2016Predictive Factors of Mortality in Population of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Results from a Korean PNH Registry. JOURNAL OF KOREAN MEDICAL SCIENCE
2017Pretreatment Epstein-Barr virus DNA in whole blood is a prognostic marker in peripheral T-cell lymphoma ONCOTARGET
2016Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple Myeloma during Treatment with Bortezomib-based Regimens JOURNAL OF KOREAN MEDICAL SCIENCE
2023Primary myelofibrosis-related glomerulopathy with renal extramedullary hematopoiesisJOURNAL OF NEPHROLOGY
2016Prognostic Impact of IPSS-R and Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic Syndrome PLOS ONE
2017Prognostic significance of interventricular septal thickness in patients with AL amyloidosisLEUKEMIA RESEARCH
2017Programmed cell death 1 expression is associated with inferior survival in patients with primary central nervous system lymphoma ONCOTARGET
2007Protein kinase CK2α as an unfavorable prognostic marker and novel therapeutic target in acute myeloid leukemia CLINICAL CANCER RESEARCH
2015Radiotherapy as an effective treatment modality for follicular lymphoma: a single institution experience RADIATION ONCOLOGY JOURNAL
2022Real-world data on prognostic value of measurable residual disease assessment by fragment analysis or next-generation sequencing in multiple myelomaBRITISH JOURNAL OF HAEMATOLOGY
2022Results of Multicenter Phase II Study With Imatinib Mesylate in Allogeneic Recipients With Steroid-Refractory Chronic GVHD CELL TRANSPLANTATION

Browse

Links